LendingTree, Inc. (TREE)
Shares of TREE climbed more than 10% in after-hours trading Monday as the company delivered another quarter of continued growth with profit and revenue numbers that handily beat analysts’ expectations
For the second quarter 2015, TREE posted record revenue of $55.1 million, a 31% increase year over year, and non-GAAP net income of $7.81 million, or $0.63 per share, compared to non-GAAP net income of $4.63 million, or $0.39 per share in the same quarter the prior year, surpassing the Capital IQ Consensus Estimate of $0.53 earnings per share on revenues of $52.35 million for the period.
According to its business outlook for the third quarter 2015, TREE expects revenue to be in a range of $60 million to $62 million, representing a 45% – 50% increase year over year.
TREE operates the nation’s leading online loan marketplace and provides consumers with an array of online tools and information to help them find the best loans for their needs.
More about LendingTree, Inc. (TREE) at www.lendingtree.com.
MedAssets, Inc. (MDAS)
Activist investment firm Starboard Value LP disclosed in a regulatory filing ( SC 13D ) with the Securities and Exchange Commission (SEC) an 8.7% (5,225,000 shares) stake in MDAS.
Starboard also reported to the SEC that it delivered on Monday a letter to MDAS‘ chairman and CEO, R. Halsey Wise, and the company’s board. According to the SEC filing, Starboard expressed in the letter its belief, among other things, that MDAS is deeply undervalued relative to the quality of its assets and the earnings power of its core business. The investment firm also outlined in the letter a plan to create significant shareholder value by reducing MDAS‘ operating expenses, improving capital allocation, improving corporate governance and exploring all available strategic alternatives.
In the letter, Starboard stated that it would like MDAS‘ management and board to consider the views of its shareholders in connection with company’s ongoing strategic review process. Starboard also expressed its belief in the letter that if MDAS were to pursue Starboard’s plan of action, the stock price of the company could be $37.00 -$46.00 by the end of 2016.
Shares of MDAS soared more than 12% in the extended session Monday following the regulatory filing.
MDAS recently reported second quarter 2015 net revenue of $190.4 million and net income of $6.3 million, or $0.10 per share for the period.
MDAS is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community.
More about MedAssets, Inc. (MDAS) at www.medassets.com.
Crown Equity Holdings Inc. (CRWE)
The company has added 184 countries, 56 dependent territories and their respective cities or communities into its CRWE WORLD ( www.crweworld.com ), a community specific news, information and engagement platform. CRWE WORLD primary goal is to become a one-stop shop for the various needs of online consumers ranging from Real Estate, Coupons & Deals, Business Directory and much more, while providing news and information.
The CRWE WORLD network will give people access to local, national and international news while also allowing them to post community-specific content related with their location. With the CRWE WORLD network, visitors will be able to change its location to other communities globally to discover information in reference to the location selected.
The CRWE WORLD network will provide businesses a tool to target its marketing message locally, nationally and internationally, as well as targeting potential consumers in a specific location, such as within a certain zip code
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE PR Finance www.finance.crwe-pr.com/disclaimer